DLB - Company ID 0001308547
The table below shows Dolby Laboratories, Inc.'s balance sheet by quarter, as reported in the company's quarterly filings. All figures are in US dollars; negative values appear in red.
| Line item | Q2 2026 | Q1 2026 | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 |
|---|---|---|---|---|---|---|
| Cash & equivalents | $594.28M | $643.85M | $698.57M | $626.55M | $520.82M | $741.64M |
| Short-term investments | $460.00K | $739.00K | $763.00K | - | - | $127.32M |
| Receivables | $391.29M | $373.09M | $297.61M | $314.11M | $339.30M | $285.84M |
| Inventory | $31.93M | $31.26M | $32.41M | $34.59M | $31.83M | $34.72M |
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| Total current assets |
| $1.41B |
| $1.41B |
| $1.34B |
| $1.39B |
| $1.29B |
| $1.47B |
| Property, plant & equipment | $461.84M | $466.72M | $478.48M | $472.66M | $476.11M | $477.69M |
| Goodwill | $529.67M | $530.30M | $528.82M | $525.02M | $520.42M | $408.46M |
| Total assets | $3.25B | $3.19B | $3.20B | $3.23B | $3.16B | $2.97B |
| Accounts payable | $20.69M | $8.67M | $17.23M | $17.29M | $11.55M | $16.41M |
| Total current liabilities | $474.61M | $443.51M | $388.79M | $457.49M | $441.88M | $354.54M |
| Long-term debt | - | - | - | - | - | - |
| Total liabilities | $622.36M | $589.25M | $581.75M | $646.02M | $641.57M | $526.20M |
| Retained earnings | $2.63B | $2.60B | $2.62B | $2.60B | $2.54B | $2.46B |
| Total equity | $2.62B | $2.59B | $2.60B | $2.57B | $2.51B | $2.43B |